Kestrel Group Reports First Quarter 2026 Financial Results

Go back to Kestrel Group Reports First Quarter 2026 Financial Results
KING PHARMACEUTICALS (NASDAQ: KG) Delayed: 7.58 --0 (-0%)
Previous Close $7.58    52 Week High $14.26 
Open $7.58    52 Week Low $7.18 
Day High $7.58    P/E 22.29 
Day Low $7.58    EPS $0.34 
Volume